MacroGenics's market cap is currently $179.50M. The company's EPS TTM is $-1.571; its P/E ratio is ―; MacroGenics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 58.75M	$ 151.94M	$ 75.64M	$ 97.76M	$ 62.02M
Gross Profit	$ 50.53M	$ 144.56M	$ 72.99M	$ -95.44M	$ -133.28M
Operating Income	$ -168.24M	$ -121.42M	$ -202.79M	$ -131.06M	$ -177.19M
EBITDA	$ 2.02M	$ -107.89M	$ -190.86M	$ -117.78M	$ -177.19M
Net Income	$ -9.06M	$ -120.02M	$ -190.86M	$ -117.78M	$ -151.81M
Balance Sheet
Cash & Short-Term Investments	$ 229.81M	$ 154.35M	$ 243.62M	$ 272.53M	$ 215.76M
Total Assets	$ 298.42M	$ 280.47M	$ 335.25M	$ 378.74M	$ 312.50M
Total Debt	$ 33.97M	$ 34.83M	$ 25.47M	$ 29.25M	$ 30.57M
Net Debt	$ -66.98M	$ -74.05M	$ -98.00M	$ -151.88M	$ -95.90M
Total Liabilities	$ 145.81M	$ 138.46M	$ 95.63M	$ 82.86M	$ 81.87M
Stockholders' Equity	$ 152.61M	$ 142.01M	$ 239.62M	$ 295.88M	$ 230.63M
Cash Flow
Free Cash Flow	$ -79.97M	$ -90.58M	$ -150.03M	$ -117.80M	$ -138.56M
Operating Cash Flow	$ -78.20M	$ -86.96M	$ -143.83M	$ -111.90M	$ -134.27M
Investing Cash Flow	$ -80.08M	$ 70.72M	$ -36.61M	$ -7.79M	$ -79.36M
Financing Cash Flow	$ 150.36M	$ 1.66M	$ 122.78M	$ 174.34M	$ 119.97M

Currency in USD

MacroGenics Earnings and Revenue History

Income Statement >

MacroGenics Debt to Assets

Balance Sheet >

MacroGenics Cash Flow

Cash Flow >

MacroGenics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing